Literature DB >> 20367797

Indicators and outcome of liver transplantation in acute liver decompensation after flares of hepatitis B.

W-C Lee1, H-S Chou, T-J Wu, C-S Lee, C-F Lee, K-M Chan.   

Abstract

Non-cirrhotic patients having acute liver decompensation in flares of hepatitis B can recover spontaneously or die without liver transplantation. Criteria for identifying patients in need of liver transplantation are lacking. Fifty-one non-cirrhotic patients having acute liver decompensation in flares of hepatitis B were retrospectively reviewed. The patients were divided into three groups: group A patients (n=18) recovered from acute liver decompensation spontaneously; group B patients (n=22) died of acute liver failure; and group C patients (n=11) had liver transplantation. Model of end-stage liver disease (MELD) scores were evaluated to identify the criteria for liver transplantation. The cut-off point of MELD scores for liver transplantation was evaluated by receiver operating characteristic (ROC) curve. Comparing group A and B patients, MELD score was an independent factor to predict prognosis. By analysing ROC curve, a MELD score>30 was the most optimal cut-off point to indicate liver transplantation; however, the false positive rate was 11.1%. By weekly measurement of MELD scores, subsequent increase in MELD scores could help to avoid false positives. Moreover, a MELD score>34 yielded 0% false positive rate and indicated the necessity of definite liver transplantation. For group C patients, ten of 11 patients were saved by liver transplantation. In conclusion, for the patients having acute liver decompensation in flares of hepatitis B, liver transplantation is definitely indicated by MELD scores>34. Liver transplantation is also indicated if the MELD score increases in the subsequent 1-2 weeks. Liver transplantation has a good outcome if performed on time.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 20367797     DOI: 10.1111/j.1365-2893.2010.01295.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  9 in total

1.  Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.

Authors:  Cyriac Abby Philips; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

2.  Management of chronic hepatitis B in severe liver disease.

Authors:  James Fung; Ching-Lung Lai; Man-Fung Yuen
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

4.  Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.

Authors:  Ricardo Salinas Saldaña; Harald Schrem; Marc Barthold; Alexander Kaltenborn
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

5.  Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.

Authors:  Jung Min Ha; Won Sohn; Ju Yeon Cho; Jeung Hui Pyo; Kyu Choi; Dong Hyun Sinn; Geum-Youn Gwak; Moon Seok Choi; Joon Hyeok Lee; Kwang Chul Koh; Seung Woon Paik; Byung Chul Yoo; Yong-Han Paik
Journal:  Clin Mol Hepatol       Date:  2015-09-30

6.  Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure.

Authors:  Yun-Hao Xun; Jun-Ping Shi; Chun-Qing Li; Dan Li; Wei-Zhen Shi; Qing-Chun Pan; Jian-Chun Guo; Guo-Qing Zang
Journal:  Mol Med Rep       Date:  2014-02-25       Impact factor: 2.952

7.  Validation of the Model for End-Stage Liver Disease Score Criteria in Urgent Liver Transplantation for Acute Flare Up of Hepatitis B.

Authors:  Wei-Chen Lee; Ching-Song Lee; Yu-Chao Wang; Chih-Hsien Cheng; Tsung-Han Wu; Chen-Fang Lee; Ruey-Shyang Soong; Ming-Ling Chang; Ting-Jung Wu; Hong-Shiue Chou; Kun-Ming Chan
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Significance of Hepatitis B Recurrence in Liver Transplantation Recipients.

Authors:  Hong-Shiue Chou; Chih-Hsien Cheng; Hao-Chien Hung; Jin-Chiao Lee; Yu-Chao Wang; Tsung-Han Wu; Chen-Fang Lee; Ting-Jung Wu; Kun-Ming Chan; Wei-Chen Lee
Journal:  Biomed Res Int       Date:  2020-08-24       Impact factor: 3.411

9.  Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation.

Authors:  Wei-Chen Lee; Chen-Fang Lee; Tsung-Han Wu; Hao-Chien Hung; Jin-Chiao Lee; Yu-Chao Wang; Chih-Hsien Cheng; Ting-Jung Wu; Hong-Shiue Chou; Kun-Ming Chan
Journal:  J Pers Med       Date:  2021-12-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.